As an end-to-end CRO/CDMO service provider, Genevoyager has extensive experience and a proven track record of success in supporting clinical-stage gene therapy and innovative vaccine programs. We are committed to advancing innovative technologies high-quality AAV,and recombinant protein products for infeinfectious diseases and therapeutic vaccines, and lentivirus as well as oncolytic virus (adenovirus, VSV, HSV), featuring improved yields, minimal impurities, consistent scale up and batch quality, enhanced biological activity, and reduced costs. Collaboration with Genevoyager will help our clients to faster the speed from basic discovery to clinical study and empower our clients more competity based on our innovative technologies and experienced team.

Genevoyager

Org chart

Teams

Offices

Genevoyager

Org chart

Teams

Offices

Related companies